BioGenes has significant experience in the development of highly sensitive sandwich ELISAs, which are used to quantify biologics in PK studies and routine drug monitoring in human and animal serum, as well as for the comparative assessment of biosimilars versus originators.
- Development of monoclonal antibodies and anti-IDs
- Pair search
- ELISA method development and assay optimization
- Testing of matrix effects pre-validation
- Method transfer to a GLP laboratory or to the customer